F Blueprint Medicines Corp Transaction History
F
- $2.26 Billion
- Q4 2024
A detailed history of F transactions in Blueprint Medicines Corp stock. As of the latest transaction made, F holds 31,313 shares of BPMC stock, worth $2.98 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
31,313Holding current value
$2.98 Million% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
373Shares Held
65.1MCall Options Held
2.25MPut Options Held
1.01M-
Vanguard Group Inc Valley Forge, PA6.77MShares$645 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$633 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$541 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA4.28MShares$408 Million0.07% of portfolio
-
State Street Corp Boston, MA2.5MShares$238 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.68B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...